IDEXX Laboratories: MACD Death Cross and Bollinger Bands indicate bearish momentum.

IDEXX Laboratories's 15-minute chart has triggered a MACD Death Cross and Bollinger Bands Expanding Downward as of 12:45 PM on August 20th, 2025. This indicates that the stock price may continue to decline, with the market trend being driven by sellers.

IDEXX Laboratories' stock (IDXX) has recently shown significant bearish indicators on its 15-minute chart, triggering a MACD Death Cross and Bollinger Bands Expanding Downward as of 12:45 PM on August 20th, 2025. These technical indicators suggest that the stock price may continue to decline in the near term, driven primarily by selling pressure [2].

The MACD Death Cross is a technical indicator that signals a potential reversal in the market trend. When the MACD line crosses below the signal line, it indicates a bearish trend. The Bollinger Bands expanding downward also suggest increased volatility and selling pressure, indicating that the stock price is likely to continue its downward momentum [1].

Despite these bearish indicators, IDEXX Laboratories has shown strong performance in recent quarters. The company reported robust second-quarter earnings and raised its full-year 2025 revenue and earnings guidance [3]. However, the market volatility and technical signals suggest that investors should remain vigilant. High-beta investors should consider the potential for short-term volatility and monitor the stock closely for further developments.

Investors should also be aware of potential entry points and risk management strategies. For example, if the Relative Strength Index (RSI) dips below 30 and the stock finds support at $65.83, this could signal a short-term buying opportunity. Additionally, IDEXX's Q1 2026 earnings report on August 7, 2026, could be a pivotal event. A beat on revenue or earnings per share (EPS) could spark a rally. Furthermore, recent price targets reflect confidence in the company's long-term potential. A sustained move above $75.21 could validate the consensus [1].

In conclusion, the bearish trend indicated by the 15-minute chart's technical indicators suggests that IDEXX Laboratories' stock is likely to continue its downward momentum. However, the company's strategic positioning and continued innovation in pet healthcare provide a long-term growth story. For disciplined investors, a strategic entry point could be a pullback to $65–$66, where the RSI and support levels align with a potential rebound. Position sizing is crucial, with a stop-loss at $62 to balance exposure with risk management [1].

References:
[1] https://www.ainvest.com/news/idexx-laboratories-15min-chart-shows-bollinger-bands-narrowing-kdj-death-cross-2508/
[2] https://www.ainvest.com/news/idex-15min-chart-triggers-macd-death-cross-bollinger-bands-expand-downward-2508/
[3] https://www.ainvest.com/news/idexx-laboratories-powerhouse-veterinary-diagnostics-strong-q2-2025-outperformance-strategic-innovation-2508/